These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 32173135)

  • 1. Pharmacologic Cardioversion of Recent-Onset Atrial Fibrillation and Flutter in the Emergency Department: A Systematic Review and Network Meta-analysis.
    deSouza IS; Tadrous M; Sexton T; Benabbas R; Carmelli G; Sinert R
    Ann Emerg Med; 2020 Jul; 76(1):14-30. PubMed ID: 32173135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic cardioversion of recent-onset atrial fibrillation: a systematic review and network meta-analysis.
    deSouza IS; Tadrous M; Sexton T; Benabbas R; Carmelli G; Sinert R
    Europace; 2020 Jun; 22(6):854-869. PubMed ID: 32176779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. External electrical and pharmacological cardioversion for atrial fibrillation, atrial flutter or atrial tachycardias: a network meta-analysis.
    Kukendrarajah K; Ahmad M; Carrington M; Ioannou A; Taylor J; Razvi Y; Papageorgiou N; Mead GE; Nevis IF; D'Ascenzo F; Wilton SB; Lambiase PD; Morillo CA; Kwong JS; Providencia R
    Cochrane Database Syst Rev; 2024 Jun; 6(6):CD013255. PubMed ID: 38828867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Effectiveness of Antidysrhythmic Drugs for Pharmacologic Cardioversion of Recent-Onset Atrial Fibrillation: a Systematic Review and Bayesian Network Meta-analysis.
    deSouza IS; Shrestha P; Allen R; Koos J; Thode H
    Cardiovasc Drugs Ther; 2024 Feb; ():. PubMed ID: 38324103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-dose oral anti-arrhythmic drugs for cardioversion of recent-onset atrial fibrillation: a systematic review and network meta-analysis of randomized controlled trials.
    Ibrahim OA; Belley-Côté EP; Um KJ; Baranchuk A; Benz AP; Dalmia S; Wang CN; Alhazzani W; Conen D; Devereaux PJ; Whitlock RP; Healey JS; McIntyre WF
    Europace; 2021 Aug; 23(8):1200-1210. PubMed ID: 33723602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Early Pharmacologic Cardioversion vs. Non-early Cardioversion in the Patients With Recent-Onset Atrial Fibrillation Within 4-Week Follow-Up Period: A Systematic Review and Network Meta-Analysis.
    Tang Y; Wang Y; Sun X; Shi Y; Liu S; Jiang W; Yuan H; Lu Y; Cai J; Wu J
    Front Cardiovasc Med; 2022; 9():843939. PubMed ID: 35479281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ibutilide Effectiveness and Safety in the Cardioversion of Atrial Fibrillation and Flutter in the Community Emergency Department.
    Vinson DR; Lugovskaya N; Warton EM; Rome AM; Stevenson MD; Reed ME; Nagam MR; Ballard DW;
    Ann Emerg Med; 2018 Jan; 71(1):96-108.e2. PubMed ID: 28969929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic Cardioversion in Patients with Paroxysmal Atrial Fibrillation: A Network Meta-Analysis.
    Tsiachris D; Doundoulakis I; Pagkalidou E; Kordalis A; Deftereos S; Gatzoulis KA; Tsioufis K; Stefanadis C
    Cardiovasc Drugs Ther; 2021 Apr; 35(2):293-308. PubMed ID: 33400054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ibutilide: an antiarrhythmic agent for the treatment of atrial fibrillation or flutter.
    Howard PA
    Ann Pharmacother; 1999 Jan; 33(1):38-47. PubMed ID: 9972384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators.
    Stambler BS; Wood MA; Ellenbogen KA; Perry KT; Wakefield LK; VanderLugt JT
    Circulation; 1996 Oct; 94(7):1613-21. PubMed ID: 8840852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dofetilide: a review of its use in atrial fibrillation and atrial flutter.
    McClellan KJ; Markham A
    Drugs; 1999 Dec; 58(6):1043-59. PubMed ID: 10651390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological cardioversion for atrial fibrillation and flutter.
    Cordina J; Mead G
    Cochrane Database Syst Rev; 2005 Apr; (2):CD003713. PubMed ID: 15846675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digoxin for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.
    Sethi NJ; Nielsen EE; Safi S; Feinberg J; Gluud C; Jakobsen JC
    PLoS One; 2018; 13(3):e0193924. PubMed ID: 29518134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vernakalant for cardioversion of recent-onset atrial fibrillation: a systematic review and meta-analysis.
    McIntyre WF; Healey JS; Bhatnagar AK; Wang P; Gordon JA; Baranchuk A; Deif B; Whitlock RP; Belley-Côté ÉP
    Europace; 2019 Aug; 21(8):1159-1166. PubMed ID: 31292622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation.
    Volgman AS; Carberry PA; Stambler B; Lewis WR; Dunn GH; Perry KT; Vanderlugt JT; Kowey PR
    J Am Coll Cardiol; 1998 May; 31(6):1414-9. PubMed ID: 9581743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ibutilide to expedite ED therapy for recent-onset atrial fibrillation flutter.
    Mountantonakis SE; Moutzouris DA; Tiu RV; Papaioannou GN; McPherson CA
    Am J Emerg Med; 2006 Jul; 24(4):407-12. PubMed ID: 16787796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review and meta-analysis of the efficacy of cardioversion by vernakalant and comparators in patients with atrial fibrillation.
    Bash LD; Buono JL; Davies GM; Martin A; Fahrbach K; Phatak H; Avetisyan R; Mwamburi M
    Cardiovasc Drugs Ther; 2012 Apr; 26(2):167-79. PubMed ID: 22418856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WITHDRAWN: Pharmacological cardioversion for atrial fibrillation and flutter.
    Cordina J; Mead GE
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD003713. PubMed ID: 29140557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous Flecainide for Emergency Department Management of Acute Atrial Fibrillation.
    Markey GC; Salter N; Ryan J
    J Emerg Med; 2018 Mar; 54(3):320-327. PubMed ID: 29269083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of ibutilide in cardioversion of atrial flutter and fibrillation.
    Nair M; George LK; Koshy SK
    J Am Board Fam Med; 2011; 24(1):86-92. PubMed ID: 21209348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.